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Letter to the Editor 
CETP-catalysed transfer of cholesterylesters from 
HDL to apo B-containing lipoproteins in plasma from 
diabetic patients 
Sir, 
A recent issue of the EJCI includes a paper entitled 
Decreased ability of high density lipoproteins to transfer 
cholesterol esters in non-insulin-dependent diabetes mel- 
litus by Ahnadi et al. [l]. 
The idea that some patients with abnormal plasma 
lipoproteins, including those with non-insulin-depen- 
dent diabetes mellitus (NIDDM), have an impaired 
transfer of cholesterylesters (CE) from HDL to apo B- 
containing lipoproteins was reported first by Fielding 
et al. [2]. However, other investigators subsequently 
showed increased transfer rates in dyslipidaemic 
plasma [3]. In addition, it was found that net mass CE 
transfer is accelerated in plasma from insulin-depen- 
dent diabetes mellitus (IDDM) patients [4]. The 
plasma activity level of cholesteryl ester transfer 
protein (CETP) is also increased in complicated 
IDDM [5]. 
The work by Ahnadi et al. [ I ]  intends to contribute 
to the solution of the above-mentioned apparent 
discrepancy by using an in vitro CE transfer assay, 
specifically designed to measure the effects of HDL 
structure on CE transfer. The authors conclude that 
patients with NIDDM have an impaired transfer of 
CE, which is caused partly by a decreased ability of 
HDL to act as a CE donor. 
Although the data are obtained using adequate 
methodology, it is my opinion that this conclusion 
cannot be drawn from the present experiments, 
because the data obtained in vitro cannot be extrapo- 
lated to the in vivo situation. In a way the authors seem 
to agree with this opinion, as suggested by the last line 
of their discussion. The reason for the observed low in 
vitro rates of CE transfer, using HDL from NIDDM 
patients, may very well be that the CE transfer rates are 
actually elevated in these patients, resulting in low 
HDL2 and total HDL-cholesterol, with obvious effects 
on overall HDL structure. Thus, an accelerated in vivo 
transfer could drain the HDL from part of its CE, 
making the isolated HDL an inferior CE donor in 
vitro. This possible mechanism has not been recog- 
nized by the authors, but may very well explain their 
results. 
It appears that plasma CETP activity levels and the 
constellation of acceptor lipoproteins are important 
factors determining the net mass transfer of CE. Active 
transfer of HDL-CE into the VLDL-LDL pathway 
may occur in diabetes mellitus, contributing to the 
tendency for low HDL-cholesterol. Elevated plasma 
free fatty acids could further accelerate this process [6]. 
On the contrary, net mass transfer of CE from LDL to 
HDL may occur in healthy normolipidemic indi- 
viduals, resulting in high HDL-cholesterol [7]. 
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